Samsung Biologics records sales of KRW 131 billion and profits of KRW 10 billion in 1Q 2018
Samsung Biologics Co., Ltd. (CEO: Tae Han Kim) today announced its financial results for the first quarter in 2018. The company posted quarterly sales of KRW 131 billion and quarterly operating profits of KRW 10 billion.
Sales and operating profits of Samsung Biologics decreased KRW 35.3 billion and KRW 40.6 billion respectively QoQ, driven by the changes in product mix. However sales increased by KRW 23.4 billion and operating profit increased by KRW 6.6 billion from the same period of last year, due to the continuous increase in the capacity utilization rate of the second plant.
Net loss records KRW 47.1 billion due to the unrealized gains and losses of the company’s subsidiary Samsung Bioepis.
※ Samsung Biologics Financial Result 1Q 2018 (Billion won)
| '18. 1Q | '17. 4Q | QoQ | '17 1Q | YoY |
Sales | 131 | 166.3 | -35.3(21.2%) | 107.6 | +23.4(21.7%) |
Operating Profit | 10 | 50.6 | -40.6(80.2%) | 3.4 | +6.6(194.1%) |
Net Profit | -57.2 | -10.1 | -47.1(466.3%) | 33.1 | -24.1(72.8%) |
Samsung Biologics records sales of KRW 131 billion and profits of KRW 10 billion in 1Q 2018
Samsung Biologics Co., Ltd. (CEO: Tae Han Kim) today announced its financial results for the first quarter in 2018. The company posted quarterly sales of KRW 131 billion and quarterly operating profits of KRW 10 billion.
Sales and operating profits of Samsung Biologics decreased KRW 35.3 billion and KRW 40.6 billion respectively QoQ, driven by the changes in product mix. However sales increased by KRW 23.4 billion and operating profit increased by KRW 6.6 billion from the same period of last year, due to the continuous increase in the capacity utilization rate of the second plant.
Net loss records KRW 47.1 billion due to the unrealized gains and losses of the company’s subsidiary Samsung Bioepis.
※ Samsung Biologics Financial Result 1Q 2018 (Billion won)
| '18. 1Q | '17. 4Q | QoQ | '17 1Q | YoY |
Sales | 131 | 166.3 | -35.3(21.2%) | 107.6 | +23.4(21.7%) |
Operating Profit | 10 | 50.6 | -40.6(80.2%) | 3.4 | +6.6(194.1%) |
Net Profit | -57.2 | -10.1 | -47.1(466.3%) | 33.1 | -24.1(72.8%) |
Share article
Related Content